View drug registration information details.
Items | Registration information |
ID | 194 |
No | 194 |
Brand Name | PONADX |
Ingredients | PONATINIB 15 MG |
Dosage Form | FILM COATED TABLET |
Primary Packaging | BOTTLE |
Storage | STORE BELOW 30 C |
Shelf Life | 2 YEARS |
Pack Size | BOX OF 30'S/BOTTLE |
Dispensing Category | PRESCRIPTION |
ATC Classification | |
Pharmaceutical Class | ANTINEOPLASTIC |
Indications | FOR THE TREATMENT OF ADULT PATIENTS WITH CHRONIC PHASE, ACCELERATED PHASE OR BLAST PHASE CHRONIC MYELOID LEUKEMIA THAT IS RESISTANT OR INTOLERANT TO PRIOR TYROSINE KINASE INHIBITOR THERAPY OR PHILADELPHIA CHROMOSOME POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA THAT IS REISISTANT OR INTOLERANT TO PRIOR TYROSINE KINASE INHIBIOTR THERAPY |
Contraindications | |
Side Effects | |
Unit Price | |
EDL |
No |
Description | WHITE TABLETS |
Note | |
License Owner | BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
Manufacturer | BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
Country | LAOS |
Import Registration No | |
Import Registration Date | |
Activity | CERTIFICATE RELEASED |
Applied Date | |
FDD Registration No | 11 L 1249/24 |
FDD Registration Date | 2024-12-03 |
Expiry Date | 2029-12-02 |
Back to drug list
|